| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.742 | 0.003 | 0.742 | Anesthetic local | 0.383 0.007 DBMET02977 | ||
| 0.615 | 0.017 | 0.679 | Cholesterol antagonist | 0.679 0.009 DBMET02977 | DBMET02977 | |
| 0.565 | 0.012 | 0.61 | GABA C receptor rho-3 antagonist | 0.61 0.006 DBMET02977 | DBMET02977 | |
| 0.553 | 0.021 | 0.553 | Vasodilator, peripheral | 0.44 0.043 DBMET02977 | ||
| 0.524 | 0.006 | 0.524 | Anesthetic general | 0.371 0.02 DBMET02977 | ||
| 0.516 | 0.022 | 0.516 | Calcium channel L-type activator | 0.406 0.077 DBMET02977 | ||
| 0.516 | 0.024 | 0.596 | Histamine release inhibitor | 0.596 0.01 DBMET02977 | DBMET02977 | |
| 0.504 | 0.015 | 0.504 | Vasodilator, coronary | 0.36 0.05 DBMET02977 | ||
| 0.486 | 0.037 | 0.63 | 5 Hydroxytryptamine release inhibitor | 0.63 0.008 DBMET02977 | DBMET02977 | |
| 0.443 | 0.041 | 0.443 | Calpain 2 inhibitor | 0.394 0.065 DBMET02977 | ||
| 0.374 | 0.036 | 0.374 | Calcium channel activator | 0.273 0.12 DBMET02977 | ||
| 0.316 | 0.005 | 0.316 | GABA C receptor rho-2 antagonist | 0.283 0.007 DBMET02977 | ||
| 0.346 | 0.035 | 0.346 | Amyloid beta aggregation inhibitor | 0.296 0.046 DBMET02977 | ||
| 0.309 | 0.004 | 0.309 | Photosensitizer | 0.205 0.012 DBMET02977 | ||
| 0.303 | 0.005 | 0.303 | Calcium antagonist | 0.103 0.046 DBMET02977 | ||
| 0.358 | 0.062 | 0.358 | Immunostimulant | 0.347 0.065 DBMET02977 | ||
| 0.333 | 0.043 | 0.361 | Antiamyloidogenic | 0.361 0.036 DBMET02977 | DBMET02977 | |
| 0.312 | 0.025 | 0.39 | Gastrin inhibitor | 0.39 0.005 DBMET02977 | DBMET02977 | |
| 0.322 | 0.035 | 0.555 | 5 Hydroxytryptamine uptake stimulant | 0.555 0.003 DBMET02977 | DBMET02977 | |
| 0.335 | 0.057 | 0.335 | Spasmolytic | 0.25 0.091 DBMET02977 | ||
| 0.33 | 0.053 | 0.397 | Sodium/bile acid cotransporter inhibitor | 0.397 0.018 DBMET02977 | DBMET02977 | |
| 0.318 | 0.042 | 0.318 | Vasodilator | 0.178 0.123 DBMET02977 | ||
| 0.338 | 0.069 | 0.424 | Antithrombotic | 0.424 0.044 DBMET02977 | DBMET02977 | |
| 0.275 | 0.007 | 0.275 | Cyclooxygenase 3 inhibitor | 0.21 0.015 DBMET02977 | ||
| 0.294 | 0.028 | 0.304 | DNA methyltransferase I inhibitor | 0.304 0.025 DBMET02977 | DBMET02977 | |
| 0.309 | 0.053 | 0.309 | DNA damaging | 0.265 0.073 DBMET02977 | ||
| 0.259 | 0.006 | 0.259 | Gastric antisecretory | 0.153 0.026 DBMET02977 | ||
| 0.307 | 0.054 | 0.349 | Insulysin inhibitor | 0.349 0.035 DBMET02977 | DBMET02977 | |
| 0.298 | 0.049 | 0.391 | Interleukin agonist | 0.391 0.02 DBMET02977 | DBMET02977 | |
| 0.264 | 0.015 | 0.264 | Calcium channel blocker | 0.11 0.1 DBMET02977 | ||
| 0.253 | 0.009 | 0.253 | Toll-Like receptor 2 antagonist | 0.204 0.022 DBMET02977 | ||
| 0.253 | 0.014 | 0.253 | Nav1.3 sodium channel blocker | 0.148 0.049 DBMET02977 | ||
| 0.267 | 0.04 | 0.288 | DNA methylase inhibitor | 0.288 0.031 DBMET02977 | DBMET02977 | |
| 0.231 | 0.005 | 0.231 | Interferon agonist | 0.169 0.008 DBMET02977 | ||
| 0.314 | 0.088 | 0.314 | Transcription factor NF kappa B inhibitor | 0.292 0.099 DBMET02977 | ||
| 0.248 | 0.023 | 0.419 | Succinate dehydrogenase inhibitor | 0.419 0.004 DBMET02977 | DBMET02977 | |
| 0.235 | 0.011 | 0.235 | Mediator release inhibitor | 0.204 0.014 DBMET02977 | ||
| 0.259 | 0.048 | 0.259 | Platelet aggregation inhibitor | |||
| 0.216 | 0.006 | 0.329 | GABA C receptor rho-1 antagonist | 0.329 0.003 DBMET02977 | DBMET02977 | |
| 0.258 | 0.049 | 0.263 | Neuropeptide Y2 antagonist | 0.263 0.045 DBMET02977 | DBMET02977 | |
| 0.249 | 0.048 | 0.432 | Peroxidase inhibitor | 0.432 0.016 DBMET02977 | DBMET02977 | |
| 0.208 | 0.009 | 0.208 | TRPA1 agonist | 0.178 0.016 DBMET02977 | ||
| 0.203 | 0.005 | 0.206 | Ornithine decarboxylase inhibitor | 0.206 0.004 DBMET02977 | DBMET02977 | |
| 0.212 | 0.017 | 0.323 | Carbonic anhydrase XV inhibitor | 0.323 0.006 DBMET02977 | DBMET02977 | |
| 0.225 | 0.031 | 0.482 | Phospholipase C inhibitor | 0.482 0.007 DBMET02977 | DBMET02977 | |
| 0.344 | 0.15 | 0.414 | Caspase 9 stimulant | 0.414 0.103 DBMET02977 | DBMET02977 | |
| 0.233 | 0.039 | 0.261 | Lipocortins synthesis antagonist | 0.261 0.03 DBMET02977 | DBMET02977 | |
| 0.202 | 0.012 | 0.367 | GABA C receptor antagonist | 0.367 0.004 DBMET02977 | DBMET02977 | |
| 0.216 | 0.029 | 0.216 | Nav1.2 sodium channel blocker | 0.169 0.047 DBMET02977 | ||
| 0.202 | 0.018 | 0.202 | Neuropeptide Y1 antagonist | 0.175 0.035 DBMET02977 | ||
| 0.191 | 0.009 | 0.191 | Keratolytic | 0.186 0.01 DBMET02977 | ||
| 0.194 | 0.014 | 0.194 | Vanilloid 1 agonist | 0.153 0.036 DBMET02977 | ||
| 0.207 | 0.028 | 0.207 | Toll-Like receptor antagonist | 0.108 0.107 DBMET02977 | ||
| 0.193 | 0.014 | 0.282 | Sphingosine 1-phosphate receptor 5 antagonist | 0.282 0.003 DBMET02977 | DBMET02977 | |
| 0.239 | 0.063 | 0.239 | Psychostimulant | 0.228 0.067 DBMET02977 | ||
| 0.21 | 0.038 | 0.262 | Phospholipase A2 inhibitor | 0.262 0.02 DBMET02977 | DBMET02977 | |
| 0.198 | 0.027 | 0.198 | Alkylator | 0.175 0.035 DBMET02977 | ||
| 0.203 | 0.04 | 0.203 | Protein kinase stimulant | 0.179 0.05 DBMET02977 | ||
| 0.188 | 0.026 | 0.219 | Interleukin 4 antagonist | 0.219 0.018 DBMET02977 | DBMET02977 | |
| 0.187 | 0.026 | 0.187 | Antibacterial (Helicobacter pylori) | 0.136 0.06 DBMET02977 | ||
| 0.169 | 0.008 | 0.169 | Calcium channel L-type blocker | 0.085 0.035 DBMET02977 | ||
| 0.176 | 0.017 | 0.268 | Sphingosine 1-phosphate receptor 2 antagonist | 0.268 0.004 DBMET02977 | DBMET02977 | |
| 0.198 | 0.039 | 0.198 | ATPase inhibitor | 0.176 0.063 DBMET02977 | ||
| 0.176 | 0.02 | 0.274 | Catalase inhibitor | 0.274 0.007 DBMET02977 | DBMET02977 | |
| 0.234 | 0.08 | 0.234 | Calpain inhibitor | 0.229 0.086 DBMET02977 | ||
| 0.185 | 0.032 | 0.185 | CF transmembrane conductance regulator agonist | 0.183 0.034 DBMET02977 | ||
| 0.157 | 0.004 | 0.157 | Interferon inducer | 0.117 0.008 DBMET02977 | ||
| 0.234 | 0.085 | 0.6 | Superoxide dismutase inhibitor | 0.6 0.007 DBMET02977 | DBMET02977 | |
| 0.259 | 0.112 | 0.259 | Thyroid hormone beta antagonist | 0.187 0.166 DBMET02977 | ||
| 0.285 | 0.141 | 0.285 | 15-Lipoxygenase inhibitor | 0.247 0.167 DBMET02977 | ||
| 0.166 | 0.021 | 0.247 | Sphingosine 1-phosphate receptor 4 antagonist | 0.247 0.005 DBMET02977 | DBMET02977 | |
| 0.259 | 0.118 | 0.259 | Thyroid hormone antagonist | 0.202 0.16 DBMET02977 | ||
| 0.169 | 0.028 | 0.169 | Butyrylcholinesterase inhibitor | 0.148 0.035 DBMET02977 | ||
| 0.323 | 0.183 | 0.532 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.532 0.021 DBMET02977 | DBMET02977 | |
| 0.156 | 0.017 | 0.423 | Electrolyte absorption antagonist | 0.423 0.003 DBMET02977 | DBMET02977 | |
| 0.187 | 0.05 | 0.187 | MAP kinase kinase 5 inhibitor | |||
| 0.215 | 0.079 | 0.25 | RNA-directed DNA polymerase inhibitor | 0.25 0.049 DBMET02977 | DBMET02977 | |
| 0.184 | 0.05 | 0.184 | Acetylcholine M1 receptor antagonist | 0.164 0.063 DBMET02977 | ||
| 0.147 | 0.013 | 0.147 | Glutathione S-transferase inhibitor | 0.131 0.017 DBMET02977 | ||
| 0.297 | 0.163 | 0.297 | DNA directed DNA polymerase inhibitor | |||
| 0.136 | 0.004 | 0.136 | Squalene epoxidase inhibitor | 0.081 0.009 DBMET02977 | ||
| 0.153 | 0.025 | 0.304 | Adenylate kinase inhibitor | 0.304 0.007 DBMET02977 | DBMET02977 | |
| 0.147 | 0.023 | 0.147 | Toll-Like receptor 4 antagonist | |||
| 0.226 | 0.102 | 0.24 | 5 Hydroxytryptamine 1E antagonist | 0.24 0.086 DBMET02977 | DBMET02977 | |
| 0.191 | 0.07 | 0.191 | P-glycoprotein inhibitor | |||
| 0.218 | 0.098 | 0.342 | DNA synthesis inhibitor | 0.342 0.032 DBMET02977 | DBMET02977 | |
| 0.124 | 0.006 | 0.124 | Carbonic anhydrase XIV inhibitor | 0.124 0.006 DBMET02977 | ||
| 0.15 | 0.035 | 0.15 | Chelator | 0.144 0.038 DBMET02977 | ||
| 0.292 | 0.178 | 0.292 | Apoptosis agonist | 0.245 0.22 DBMET02977 | ||
| 0.124 | 0.009 | 0.124 | Beta adrenoreceptor antagonist | 0.09 0.021 DBMET02977 | ||
| 0.129 | 0.015 | 0.146 | Epoxide hydrolase inhibitor | 0.146 0.012 DBMET02977 | DBMET02977 | |
| 0.147 | 0.035 | 0.147 | Calcium channel (voltage-sensitive) blocker | |||
| 0.203 | 0.093 | 0.203 | Angiogenesis stimulant | 0.191 0.099 DBMET02977 | ||
| 0.117 | 0.007 | 0.117 | Beta 1 adrenoreceptor antagonist | 0.081 0.017 DBMET02977 | ||
| 0.169 | 0.06 | 0.169 | Melanin inhibitor | 0.153 0.078 DBMET02977 | ||
| 0.159 | 0.05 | 0.597 | Alpha-N-acetylglucosaminidase inhibitor | 0.597 0.004 DBMET02977 | DBMET02977 | |
| 0.155 | 0.048 | 0.155 | Nav1.6 sodium channel blocker | 0.114 0.106 DBMET02977 | ||
| 0.111 | 0.004 | 0.194 | Dihydropteroate synthase inhibitor | 0.194 0.003 DBMET02977 | DBMET02977 | |
| 0.111 | 0.005 | 0.111 | Alpha-mannosidase inhibitor | 0.086 0.009 DBMET02977 | ||
| 0.12 | 0.016 | 0.12 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.049 DBMET02977 | ||
| 0.14 | 0.036 | 0.154 | Caspase 3 inhibitor | 0.154 0.025 DBMET02977 | DBMET02977 | |
| 0.175 | 0.071 | 0.175 | Sigma receptor agonist | 0.171 0.073 DBMET02977 | ||
| 0.136 | 0.033 | 0.136 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.155 | 0.052 | 0.155 | Acetylcholinesterase inhibitor | 0.148 0.057 DBMET02977 | ||
| 0.112 | 0.011 | 0.112 | Potassium channel (ATP-sensitive) blocker | 0.085 0.024 DBMET02977 | ||
| 0.107 | 0.006 | 0.141 | Sphingosine 1-phosphate receptor 3 antagonist | 0.141 0.004 DBMET02977 | DBMET02977 | |
| 0.164 | 0.066 | 0.164 | Cholinergic | 0.137 0.089 DBMET02977 | ||
| 0.237 | 0.14 | 0.271 | Apoptosis antagonist | 0.271 0.108 DBMET02977 | DBMET02977 | |
| 0.102 | 0.008 | 0.102 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.193 | 0.1 | 0.195 | Nitric-oxide synthase stimulant | 0.195 0.097 DBMET02977 | DBMET02977 | |
| 0.198 | 0.105 | 0.659 | Aldehyde oxidase inhibitor | 0.659 0.012 DBMET02977 | DBMET02977 | |
| 0.232 | 0.14 | 0.355 | Interleukin 2 agonist | 0.355 0.043 DBMET02977 | DBMET02977 | |
| 0.144 | 0.051 | 0.251 | Aldehyde dehydrogenase inhibitor | 0.251 0.018 DBMET02977 | DBMET02977 | |
| 0.112 | 0.02 | 0.366 | GABA aminotransferase inhibitor | 0.366 0.003 DBMET02977 | DBMET02977 | |
| 0.167 | 0.076 | 0.191 | Antipruritic | 0.191 0.055 DBMET02977 | DBMET02977 | |
| 0.095 | 0.006 | 0.095 | Mannosidase inhibitor | 0.093 0.006 DBMET02977 | ||
| 0.114 | 0.028 | 0.121 | Interleukin 5 antagonist | 0.121 0.023 DBMET02977 | DBMET02977 | |
| 0.144 | 0.059 | 0.189 | Ca2+-transporting ATPase inhibitor | 0.189 0.005 DBMET02977 | DBMET02977 | |
| 0.113 | 0.029 | 0.146 | Adrenaline agonist | 0.146 0.015 DBMET02977 | DBMET02977 | |
| 0.152 | 0.067 | 0.197 | Thiol protease inhibitor | 0.197 0.04 DBMET02977 | DBMET02977 | |
| 0.191 | 0.108 | 0.228 | Platelet antagonist | 0.228 0.083 DBMET02977 | DBMET02977 | |
| 0.24 | 0.156 | 0.331 | Immunosuppressant | 0.331 0.097 DBMET02977 | DBMET02977 | |
| 0.146 | 0.063 | 0.165 | Neurotrophic factor | 0.165 0.047 DBMET02977 | DBMET02977 | |
| 0.163 | 0.081 | 0.307 | Dual specificity phosphatase inhibitor | 0.307 0.027 DBMET02977 | DBMET02977 | |
| 0.114 | 0.034 | 0.184 | Histamine N-methyltransferase inhibitor | 0.184 0.007 DBMET02977 | DBMET02977 | |
| 0.153 | 0.075 | 0.223 | Diuretic | 0.223 0.036 DBMET02977 | DBMET02977 | |
| 0.239 | 0.162 | 0.239 | Beta lactamase inhibitor | |||
| 0.135 | 0.058 | 0.19 | DNA polymerase I inhibitor | 0.19 0.031 DBMET02977 | DBMET02977 | |
| 0.088 | 0.011 | 0.093 | Purinergic P2Y antagonist | 0.093 0.01 DBMET02977 | DBMET02977 | |
| 0.126 | 0.05 | 0.532 | Ferrochelatase inhibitor | 0.532 0.002 DBMET02977 | DBMET02977 | |
| 0.156 | 0.081 | 0.191 | Arachidonic acid antagonist | 0.191 0.042 DBMET02977 | DBMET02977 | |
| 0.158 | 0.083 | 0.194 | Neurotensin receptor agonist | 0.194 0.038 DBMET02977 | DBMET02977 | |
| 0.082 | 0.008 | 0.082 | Glutamate (mGluR1a) antagonist | |||
| 0.134 | 0.059 | 0.201 | Cathepsin H inhibitor | 0.201 0.022 DBMET02977 | DBMET02977 | |
| 0.122 | 0.051 | 0.232 | Aminopeptidase B inhibitor | 0.232 0.015 DBMET02977 | DBMET02977 | |
| 0.111 | 0.041 | 0.115 | Glutamate (mGluR7) agonist | 0.115 0.035 DBMET02977 | DBMET02977 | |
| 0.194 | 0.124 | 0.194 | Cardiotonic | |||
| 0.077 | 0.008 | 0.1 | Heparanase inhibitor | 0.1 0.004 DBMET02977 | DBMET02977 | |
| 0.113 | 0.045 | 0.113 | Breast cancer-resistant protein inhibitor | |||
| 0.14 | 0.073 | 0.168 | Heat shock protein 70 antagonist | 0.168 0.019 DBMET02977 | DBMET02977 | |
| 0.086 | 0.019 | 0.114 | Beta 3 adrenoreceptor antagonist | 0.114 0.011 DBMET02977 | DBMET02977 | |
| 0.107 | 0.041 | 0.107 | Toll-Like receptor 3 antagonist | |||
| 0.072 | 0.006 | 0.072 | Cytokine production stimulant | 0.048 0.034 DBMET02977 | ||
| 0.076 | 0.011 | 0.101 | Lysophosphatidic acid 3 receptor antagonist | 0.101 0.005 DBMET02977 | DBMET02977 | |
| 0.102 | 0.037 | 0.102 | Transcription factor NF kappa B stimulant | 0.081 0.067 DBMET02977 | ||
| 0.157 | 0.093 | 0.169 | Amyloid beta precursor protein antagonist | 0.169 0.082 DBMET02977 | DBMET02977 | |
| 0.077 | 0.013 | 0.077 | Beta 2 adrenoreceptor antagonist | 0.067 0.019 DBMET02977 | ||
| 0.105 | 0.043 | 0.105 | Thioredoxin inhibitor | |||
| 0.155 | 0.095 | 0.173 | Catenin beta inhibitor | 0.173 0.062 DBMET02977 | DBMET02977 | |
| 0.104 | 0.044 | 0.113 | Phosphodiesterase 6D inhibitor | 0.113 0.033 DBMET02977 | DBMET02977 | |
| 0.2 | 0.141 | 0.21 | Lipoxygenase inhibitor | 0.21 0.131 DBMET02977 | DBMET02977 | |
| 0.115 | 0.057 | 0.115 | Acetylcholine release stimulant | |||
| 0.12 | 0.063 | 0.12 | Platelet activating factor antagonist | |||
| 0.073 | 0.017 | 0.073 | Toll-Like receptor 2 agonist | 0.041 0.029 DBMET02977 | ||
| 0.072 | 0.016 | 0.072 | Acetyl-CoA transferase 2 inhibitor | 0.065 0.023 DBMET02977 | ||
| 0.133 | 0.077 | 0.133 | Cytokine production inhibitor | |||
| 0.111 | 0.057 | 0.111 | CDC-like kinase 3 inhibitor | 0.106 0.066 DBMET02977 | ||
| 0.138 | 0.085 | 0.15 | Cytidine deaminase inhibitor | 0.15 0.075 DBMET02977 | DBMET02977 | |
| 0.142 | 0.089 | 0.172 | Interferon gamma antagonist | 0.172 0.055 DBMET02977 | DBMET02977 | |
| 0.078 | 0.026 | 0.145 | Neuraminidase (influenza) inhibitor | 0.145 0.008 DBMET02977 | DBMET02977 | |
| 0.094 | 0.042 | 0.118 | Histamine H2 receptor antagonist | 0.118 0.022 DBMET02977 | DBMET02977 | |
| 0.108 | 0.058 | 0.108 | Nav1.1 sodium channel blocker | 0.088 0.083 DBMET02977 | ||
| 0.073 | 0.023 | 0.073 | Acetyl-CoA transferase inhibitor | 0.068 0.026 DBMET02977 | ||
| 0.113 | 0.063 | 0.113 | GABA receptor agonist | |||
| 0.105 | 0.056 | 0.145 | Folate antagonist | 0.145 0.024 DBMET02977 | DBMET02977 | |
| 0.099 | 0.051 | 0.128 | Bile acid receptor antagonist | 0.128 0.014 DBMET02977 | DBMET02977 | |
| 0.093 | 0.046 | 0.132 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.132 0.02 DBMET02977 | DBMET02977 | |
| 0.074 | 0.028 | 0.074 | Nitric oxide donor | |||
| 0.163 | 0.116 | 0.253 | Insulin sensitizer | 0.253 0.033 DBMET02977 | DBMET02977 | |
| 0.092 | 0.045 | 0.181 | Carbonic anhydrase VI inhibitor | 0.181 0.015 DBMET02977 | DBMET02977 | |
| 0.104 | 0.058 | 0.251 | Carbonic anhydrase III inhibitor | 0.251 0.009 DBMET02977 | DBMET02977 | |
| 0.155 | 0.109 | 0.186 | Non-steroidal antiinflammatory agent | 0.186 0.082 DBMET02977 | DBMET02977 | |
| 0.061 | 0.016 | 0.174 | Dihydroorotase inhibitor | 0.174 0.004 DBMET02977 | DBMET02977 | |
| 0.11 | 0.065 | 0.142 | Mucolytic | 0.142 0.037 DBMET02977 | DBMET02977 | |
| 0.177 | 0.133 | 0.259 | Peptidyltransferase inhibitor | 0.259 0.045 DBMET02977 | DBMET02977 | |
| 0.048 | 0.004 | 0.048 | Toll-Like receptor 8 agonist | 0.032 0.004 DBMET02977 | ||
| 0.075 | 0.031 | 0.107 | Glutamate (mGluR6) antagonist | 0.107 0.008 DBMET02977 | DBMET02977 | |
| 0.101 | 0.057 | 0.101 | Interleukin 1 beta converting enzyme inhibitor | 0.101 0.056 DBMET02977 | ||
| 0.075 | 0.032 | 0.13 | NMDA receptor glycine site agonist | 0.13 0.006 DBMET02977 | DBMET02977 | |
| 0.074 | 0.03 | 0.131 | Neuraminidase inhibitor | 0.131 0.008 DBMET02977 | DBMET02977 | |
| 0.128 | 0.085 | 0.161 | Lipid peroxidase inhibitor | 0.161 0.061 DBMET02977 | DBMET02977 | |
| 0.074 | 0.034 | 0.103 | CDC25B inhibitor | 0.103 0.015 DBMET02977 | DBMET02977 | |
| 0.065 | 0.026 | 0.084 | Glucosylceramidase inhibitor | 0.084 0.013 DBMET02977 | DBMET02977 | |
| 0.06 | 0.02 | 0.071 | Adenosine deaminase inhibitor | 0.071 0.013 DBMET02977 | DBMET02977 | |
| 0.166 | 0.127 | 0.216 | Cyclic AMP phosphodiesterase inhibitor | 0.216 0.083 DBMET02977 | DBMET02977 | |
| 0.08 | 0.041 | 0.08 | Phosphodiesterase VI inhibitor | |||
| 0.053 | 0.013 | 0.062 | Beta adrenoreceptor agonist | 0.062 0.007 DBMET02977 | DBMET02977 | |
| 0.085 | 0.046 | 0.085 | Macrophage migration inhibitory factor inhibitor | |||
| 0.082 | 0.043 | 0.124 | Sphingosine 1-phosphate receptor antagonist | 0.124 0.012 DBMET02977 | DBMET02977 | |
| 0.108 | 0.07 | 0.164 | Monophenol monooxygenase inhibitor | 0.164 0.042 DBMET02977 | DBMET02977 | |
| 0.052 | 0.014 | 0.052 | Acetyl-CoA transferase 1 inhibitor | 0.05 0.017 DBMET02977 | ||
| 0.084 | 0.047 | 0.152 | Carbonic anhydrase XIII inhibitor | 0.152 0.021 DBMET02977 | DBMET02977 | |
| 0.055 | 0.018 | 0.055 | Benzodiazepine antagonist | 0.046 0.036 DBMET02977 | ||
| 0.141 | 0.104 | 0.245 | Dual specificity phosphatase 3 inhibitor | 0.245 0.042 DBMET02977 | DBMET02977 | |
| 0.162 | 0.125 | 0.237 | Hypolipemic | 0.237 0.073 DBMET02977 | DBMET02977 | |
| 0.086 | 0.049 | 0.086 | Caspase 7 inhibitor | |||
| 0.048 | 0.015 | 0.182 | Nicotinic acid receptor agonist | 0.182 0.004 DBMET02977 | DBMET02977 | |
| 0.107 | 0.075 | 0.123 | CDK3/cyclin E inhibitor | 0.123 0.052 DBMET02977 | DBMET02977 | |
| 0.064 | 0.032 | 0.064 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.091 | 0.059 | 0.097 | Glutamate release inhibitor | 0.097 0.048 DBMET02977 | DBMET02977 | |
| 0.109 | 0.078 | 0.109 | Beta amyloid protein antagonist | |||
| 0.05 | 0.018 | 0.065 | Angiotensin AT1 receptor antagonist | 0.065 0.004 DBMET02977 | DBMET02977 | |
| 0.064 | 0.033 | 0.073 | Beta 2 adrenoreceptor agonist | 0.073 0.015 DBMET02977 | DBMET02977 | |
| 0.146 | 0.115 | 0.203 | Death-associated protein kinase 2 inhibitor | 0.203 0.032 DBMET02977 | DBMET02977 | |
| 0.081 | 0.05 | 0.135 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.135 0.024 DBMET02977 | DBMET02977 | |
| 0.096 | 0.066 | 0.113 | Nitric-oxide synthase inhibitor | 0.113 0.043 DBMET02977 | DBMET02977 | |
| 0.102 | 0.072 | 0.102 | DNA intercalator | 0.101 0.073 DBMET02977 | ||
| 0.036 | 0.007 | 0.036 | Lysophosphatidic acid receptor 1 agonist | 0.035 0.007 DBMET02977 | ||
| 0.057 | 0.028 | 0.057 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.065 | 0.036 | 0.065 | Transcription factor AP-1 inhibitor | |||
| 0.188 | 0.159 | 0.293 | Tyrosine 3 hydroxylase inhibitor | 0.293 0.036 DBMET02977 | DBMET02977 | |
| 0.158 | 0.13 | 0.283 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.283 0.029 DBMET02977 | DBMET02977 | |
| 0.046 | 0.018 | 0.079 | Retinoic acid alpha receptor agonist | 0.079 0.005 DBMET02977 | DBMET02977 | |
| 0.059 | 0.032 | 0.079 | Leukotriene C antagonist | 0.079 0.008 DBMET02977 | DBMET02977 | |
| 0.084 | 0.059 | 0.084 | Vanilloid agonist | |||
| 0.056 | 0.031 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.058 | 0.033 | 0.066 | Myc inhibitor | 0.066 0.023 DBMET02977 | DBMET02977 | |
| 0.062 | 0.038 | 0.062 | Potassium channel (Ca-activated) blocker | |||
| 0.107 | 0.083 | 0.107 | Acetylcholine muscarinic antagonist | |||
| 0.057 | 0.033 | 0.084 | Thromboxane synthase inhibitor | 0.084 0.01 DBMET02977 | DBMET02977 | |
| 0.058 | 0.034 | 0.106 | Sphingosine 1-phosphate receptor 1 antagonist | 0.106 0.008 DBMET02977 | DBMET02977 | |
| 0.032 | 0.009 | 0.032 | Glucosylceramidase stimulant | |||
| 0.063 | 0.043 | 0.184 | NMDA receptor agonist | 0.184 0.005 DBMET02977 | DBMET02977 | |
| 0.056 | 0.037 | 0.204 | Acyl-CoA dehydrogenase inhibitor | 0.204 0.005 DBMET02977 | DBMET02977 | |
| 0.037 | 0.018 | 0.065 | Angiotensin II receptor antagonist | 0.065 0.004 DBMET02977 | DBMET02977 | |
| 0.029 | 0.011 | 0.052 | Retinoic acid receptor agonist | 0.052 0.005 DBMET02977 | DBMET02977 | |
| 0.156 | 0.138 | 0.185 | Free radical scavenger | 0.185 0.11 DBMET02977 | DBMET02977 | |
| 0.181 | 0.163 | 0.281 | Transcription factor STAT3 inhibitor | 0.281 0.063 DBMET02977 | DBMET02977 | |
| 0.034 | 0.017 | 0.057 | Epoxide hydrolase 1 inhibitor | 0.057 0.005 DBMET02977 | DBMET02977 | |
| 0.12 | 0.103 | 0.146 | Farnesoid X receptor antagonist | 0.146 0.058 DBMET02977 | DBMET02977 | |
| 0.036 | 0.019 | 0.041 | Calcium-independent phospholipase A2 inhibitor | 0.041 0.009 DBMET02977 | DBMET02977 | |
| 0.03 | 0.014 | 0.049 | Calcium-sensing receptor agonist | 0.049 0.005 DBMET02977 | DBMET02977 | |
| 0.043 | 0.026 | 0.131 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.131 0.002 DBMET02977 | DBMET02977 | |
| 0.023 | 0.006 | 0.042 | Carbonic anhydrase X inhibitor | 0.042 0.003 DBMET02977 | DBMET02977 | |
| 0.023 | 0.006 | 0.042 | Carbonic anhydrase VIII inhibitor | 0.042 0.003 DBMET02977 | DBMET02977 | |
| 0.102 | 0.086 | 0.102 | Microtubule formation inhibitor | 0.098 0.094 DBMET02977 | ||
| 0.046 | 0.031 | 0.047 | Oleamide hydrolase inhibitor | 0.047 0.03 DBMET02977 | DBMET02977 | |
| 0.024 | 0.009 | 0.044 | Retinoic acid beta receptor agonist | 0.044 0.004 DBMET02977 | DBMET02977 | |
| 0.058 | 0.043 | 0.058 | Heat shock protein 90 beta antagonist | |||
| 0.092 | 0.078 | 0.12 | Expectorant | 0.12 0.051 DBMET02977 | DBMET02977 | |
| 0.039 | 0.025 | 0.048 | DNA gyrase subunit B inhibitor | 0.048 0.014 DBMET02977 | DBMET02977 | |
| 0.079 | 0.065 | 0.079 | GABA A receptor agonist | |||
| 0.142 | 0.129 | 0.165 | MAP kinase kinase 2 inhibitor | 0.165 0.108 DBMET02977 | DBMET02977 | |
| 0.071 | 0.058 | 0.071 | Adenosine A3 receptor antagonist | |||
| 0.018 | 0.006 | 0.018 | Lysophosphatidic acid receptor 3 agonist | 0.014 0.009 DBMET02977 | ||
| 0.053 | 0.041 | 0.053 | Epithelial sodium channel blocker | |||
| 0.054 | 0.043 | 0.09 | Adenine nucleotide translocase inhibitor | 0.09 0.005 DBMET02977 | DBMET02977 | |
| 0.042 | 0.031 | 0.042 | Leukocyte elastase inhibitor | 0.042 0.031 DBMET02977 | ||
| 0.079 | 0.069 | 0.091 | Estrogen-related receptor beta agonist | 0.091 0.039 DBMET02977 | DBMET02977 | |
| 0.049 | 0.039 | 0.049 | H+/K+-transporting ATPase inhibitor | |||
| 0.053 | 0.042 | 0.48 | Alcohol oxidase inhibitor | 0.48 0.004 DBMET02977 | DBMET02977 | |
| 0.022 | 0.012 | 0.049 | Neuraminidase (Influenza B) inhibitor | 0.049 0.002 DBMET02977 | DBMET02977 | |
| 0.109 | 0.099 | 0.135 | NADPH oxidase inhibitor | 0.135 0.067 DBMET02977 | DBMET02977 | |
| 0.044 | 0.035 | 0.058 | Carbonic anhydrase VII inhibitor | 0.058 0.02 DBMET02977 | DBMET02977 | |
| 0.045 | 0.035 | 0.045 | Potassium channel Kv1.3 blocker | |||
| 0.034 | 0.025 | 0.07 | Phosphoglycerate kinase inhibitor | 0.07 0.009 DBMET02977 | DBMET02977 | |
| 0.019 | 0.01 | 0.024 | Ileal bile acid transport inhibitor | 0.024 0.007 DBMET02977 | DBMET02977 | |
| 0.216 | 0.209 | 0.216 | Alpha-glucosidase inhibitor | |||
| 0.134 | 0.128 | 0.143 | Hepatoprotectant | 0.143 0.118 DBMET02977 | DBMET02977 | |
| 0.027 | 0.021 | 0.027 | Hedgehog signaling activator | |||
| 0.032 | 0.027 | 0.032 | Melatonin receptor 1A agonist | |||
| 0.188 | 0.183 | 0.188 | Thioredoxin glutathione reductase inhibitor | |||
| 0.028 | 0.024 | 0.056 | Lysophosphatidic acid 2 receptor antagonist | 0.056 0.007 DBMET02977 | DBMET02977 | |
| 0.119 | 0.115 | 0.166 | Hemostatic | 0.166 0.051 DBMET02977 | DBMET02977 | |
| 0.08 | 0.076 | 0.284 | Triose-phosphate isomerase inhibitor | 0.284 0.005 DBMET02977 | DBMET02977 | |
| 0.045 | 0.042 | 0.16 | NMDA 2A receptor antagonist | 0.16 0.006 DBMET02977 | DBMET02977 | |
| 0.043 | 0.041 | 0.047 | Cholesterol esterase inhibitor | 0.047 0.034 DBMET02977 | DBMET02977 | |
| 0.027 | 0.024 | 0.027 | DNA polymerase III inhibitor | |||
| 0.027 | 0.025 | 0.062 | Purinergic P2Y14 antagonist | 0.062 0.005 DBMET02977 | DBMET02977 | |
| 0.079 | 0.077 | 0.217 | NADH dehydrogenase inhibitor | 0.217 0.009 DBMET02977 | DBMET02977 | |
| 0.161 | 0.16 | 0.184 | Hypoglycemic | 0.184 0.129 DBMET02977 | DBMET02977 | |
| 0.023 | 0.022 | 0.023 | 5 Hydroxytryptamine 4 agonist | |||
| 0.018 | 0.019 | 0.046 | Prostaglandin EP2 agonist | 0.046 0.007 DBMET02977 | DBMET02977 | |
| 0.02 | 0.021 | 0.036 | Beta 1 adrenoreceptor agonist | 0.036 0.006 DBMET02977 | DBMET02977 | |
| 0.082 | 0.083 | 0.095 | Sphingomyelinase inhibitor | 0.095 0.065 DBMET02977 | DBMET02977 | |
| 0.011 | 0.012 | 0.021 | Carbonic anhydrase XI inhibitor | 0.021 0.004 DBMET02977 | DBMET02977 | |
| 0.04 | 0.042 | 0.072 | Neuraminidase (Influenza A) inhibitor | 0.072 0.007 DBMET02977 | DBMET02977 | |
| 0.071 | 0.073 | 0.134 | Glycine receptor antagonist | 0.134 0.012 DBMET02977 | DBMET02977 | |
| 0.02 | 0.023 | 0.033 | Retinoic acid gamma receptor agonist | 0.033 0.005 DBMET02977 | DBMET02977 | |
| 0.051 | 0.054 | 0.063 | Carbonic anhydrase inhibitor | 0.063 0.044 DBMET02977 | DBMET02977 | |
| 0.041 | 0.044 | 0.051 | Parathyroid hormone antagonist | 0.051 0.021 DBMET02977 | DBMET02977 | |
| 0.036 | 0.039 | 0.052 | Leukotriene C4 antagonist | 0.052 0.009 DBMET02977 | DBMET02977 | |
| 0.052 | 0.057 | 0.075 | Sphingosine kinase inhibitor | 0.075 0.02 DBMET02977 | DBMET02977 | |
| 0.084 | 0.089 | 0.131 | Anabolic | 0.131 0.03 DBMET02977 | DBMET02977 | |
| 0.067 | 0.072 | 0.07 | Potassium channel (Tandem pore domain) blocker | 0.07 0.063 DBMET02977 | DBMET02977 | |
| 0.043 | 0.048 | 0.18 | Ornithine carbamoyltransferase inhibitor | 0.18 0.008 DBMET02977 | DBMET02977 | |
| 0.104 | 0.109 | 0.117 | Alkaline phosphatase inhibitor | 0.117 0.089 DBMET02977 | DBMET02977 | |
| 0.089 | 0.095 | 0.152 | Adenylate cyclase inhibitor | 0.152 0.044 DBMET02977 | DBMET02977 | |
| 0.077 | 0.083 | 0.125 | Aminoacyl-tRNA synthetase inhibitor | 0.125 0.027 DBMET02977 | DBMET02977 | |
| 0.008 | 0.014 | 0.018 | Beta 3 adrenoreceptor agonist | 0.018 0.005 DBMET02977 | DBMET02977 | |
| 0.039 | 0.047 | 0.078 | Thromboxane A2 antagonist | 0.078 0.016 DBMET02977 | DBMET02977 | |
| 0.044 | 0.052 | 0.138 | Aconitate hydratase inhibitor | 0.138 0.005 DBMET02977 | DBMET02977 | |
| 0.044 | 0.052 | 0.09 | Carbonic anhydrase VB inhibitor | 0.09 0.019 DBMET02977 | DBMET02977 | |
| 0.104 | 0.113 | 0.164 | Histone deacetylase SIRT1 inhibitor | 0.164 0.05 DBMET02977 | DBMET02977 | |
| 0.021 | 0.03 | 0.042 | Liver X receptor beta antagonist | 0.042 0.011 DBMET02977 | DBMET02977 | |
| 0.008 | 0.018 | 0.026 | Angiotensin AT1B receptor antagonist | 0.026 0.004 DBMET02977 | DBMET02977 | |
| 0.041 | 0.052 | 0.085 | Thromboxane antagonist | 0.085 0.017 DBMET02977 | DBMET02977 | |
| 0.05 | 0.06 | 0.064 | Selectin antagonist | 0.064 0.046 DBMET02977 | DBMET02977 | |
| 0.081 | 0.092 | 0.523 | GABA C receptor agonist | 0.523 0.003 DBMET02977 | DBMET02977 | |
| 0.053 | 0.064 | 0.128 | Carbonic anhydrase V inhibitor | 0.128 0.019 DBMET02977 | DBMET02977 | |
| 0.011 | 0.023 | 0.019 | Thromboxane A2 agonist | 0.019 0.006 DBMET02977 | DBMET02977 | |
| 0.09 | 0.102 | 0.145 | Cholesterol synthesis inhibitor | 0.145 0.047 DBMET02977 | DBMET02977 | |
| 0.055 | 0.068 | 0.065 | Histone deacetylase SIRT3 inhibitor | 0.065 0.035 DBMET02977 | DBMET02977 | |
| 0.044 | 0.057 | 0.253 | Argininosuccinate synthase inhibitor | 0.253 0.005 DBMET02977 | DBMET02977 | |
| 0.055 | 0.068 | 0.12 | Carbonic anhydrase VA inhibitor | 0.12 0.018 DBMET02977 | DBMET02977 | |
| 0.031 | 0.044 | 0.067 | Retinoid X receptor antagonist | 0.067 0.004 DBMET02977 | DBMET02977 | |
| 0.031 | 0.045 | 0.043 | Carbonic anhydrase IV inhibitor | 0.043 0.03 DBMET02977 | DBMET02977 | |
| 0.025 | 0.038 | 0.04 | Methionyl aminopeptidase 1 inhibitor | 0.04 0.012 DBMET02977 | DBMET02977 | |
| 0.055 | 0.068 | 0.079 | Lipase inhibitor | 0.079 0.044 DBMET02977 | DBMET02977 | |
| 0.093 | 0.107 | 0.114 | Cell adhesion inhibitor | 0.114 0.07 DBMET02977 | DBMET02977 | |
| 0.091 | 0.105 | 0.1 | Electron transport complex I inhibitor | 0.1 0.083 DBMET02977 | DBMET02977 | |
| 0.036 | 0.049 | 0.043 | GABA B receptor antagonist | 0.043 0.029 DBMET02977 | DBMET02977 | |
| 0.048 | 0.062 | 0.07 | Botulinum neurotoxin type A inhibitor | 0.07 0.025 DBMET02977 | DBMET02977 | |
| 0.017 | 0.031 | 0.024 | Angiotensin AT1A receptor antagonist | 0.024 0.011 DBMET02977 | DBMET02977 | |
| 0.031 | 0.046 | 0.067 | Membrane dipeptidase inhibitor | 0.067 0.008 DBMET02977 | DBMET02977 | |
| 0.016 | 0.032 | 0.038 | Lysophosphatidic acid 1 receptor antagonist | 0.038 0.005 DBMET02977 | DBMET02977 | |
| 0.079 | 0.095 | 0.11 | Xanthine oxidase inhibitor | 0.11 0.053 DBMET02977 | DBMET02977 | |
| 0.034 | 0.05 | 0.079 | Geranyltranstransferase inhibitor | 0.079 0.005 DBMET02977 | DBMET02977 | |
| 0.054 | 0.072 | 0.226 | Histidine decarboxylase inhibitor | 0.226 0.011 DBMET02977 | DBMET02977 | |
| 0.033 | 0.053 | 0.04 | Plasmepsin II inhibitor | 0.04 0.03 DBMET02977 | DBMET02977 | |
| 0.049 | 0.069 | 0.066 | Pregnane X receptor antagonist | 0.066 0.019 DBMET02977 | DBMET02977 | |
| 0.021 | 0.041 | 0.035 | Prostaglandin agonist | 0.035 0.016 DBMET02977 | DBMET02977 | |
| 0.148 | 0.168 | 0.176 | Antioxidant | 0.176 0.136 DBMET02977 | DBMET02977 | |
| 0.059 | 0.08 | 0.087 | CDC25A inhibitor | 0.087 0.036 DBMET02977 | DBMET02977 | |
| 0.025 | 0.046 | 0.092 | Nicotinic acid receptor 2 agonist | 0.092 0.006 DBMET02977 | DBMET02977 | |
| 0.025 | 0.046 | 0.047 | Carnitine palmitoyltransferase inhibitor | 0.047 0.01 DBMET02977 | DBMET02977 | |
| 0.073 | 0.095 | 0.146 | D-Ala-D-Ala ligase inhibitor | 0.146 0.006 DBMET02977 | DBMET02977 | |
| 0.035 | 0.057 | 0.092 | Glutamate (mGluR4) antagonist | 0.092 0.006 DBMET02977 | DBMET02977 | |
| 0.035 | 0.057 | 0.052 | DNA gyrase subunit A inhibitor | 0.052 0.016 DBMET02977 | DBMET02977 | |
| 0.041 | 0.063 | 0.059 | Glutamate (mGluR1) antagonist | 0.059 0.039 DBMET02977 | DBMET02977 | |
| 0.165 | 0.188 | 0.216 | 12-Lipoxygenase inhibitor | 0.216 0.135 DBMET02977 | DBMET02977 | |
| 0.067 | 0.09 | 0.081 | Inducible nitric-oxide synthase inhibitor | 0.081 0.061 DBMET02977 | DBMET02977 | |
| 0.087 | 0.11 | 0.12 | Factor V inhibitor | 0.12 0.039 DBMET02977 | DBMET02977 | |
| 0.11 | 0.135 | 0.22 | Hexokinase inhibitor | 0.22 0.025 DBMET02977 | DBMET02977 | |
| 0.063 | 0.088 | 0.074 | Cell adhesion molecule inhibitor | 0.074 0.062 DBMET02977 | DBMET02977 | |
| 0.023 | 0.048 | 0.091 | Retinoid X alpha receptor agonist | 0.091 0.006 DBMET02977 | DBMET02977 | |
| 0.037 | 0.062 | 0.06 | Diacylglycerol O-acyltransferase inhibitor | 0.06 0.026 DBMET02977 | DBMET02977 | |
| 0.035 | 0.061 | 0.059 | Carbonic anhydrase I inhibitor | 0.059 0.036 DBMET02977 | DBMET02977 | |
| 0.024 | 0.05 | 0.046 | Carnitine palmitoyltransferase 1 inhibitor | 0.046 0.01 DBMET02977 | DBMET02977 | |
| 0.02 | 0.047 | 0.08 | Retinoid X receptor agonist | 0.08 0.008 DBMET02977 | DBMET02977 | |
| 0.053 | 0.082 | 0.096 | Telomerase inhibitor | 0.096 0.035 DBMET02977 | DBMET02977 | |
| 0.018 | 0.048 | 0.041 | Vanilloid 2 agonist | 0.041 0.004 DBMET02977 | DBMET02977 | |
| 0.046 | 0.076 | 0.092 | Sphingosine 1-phosphate receptor 4 agonist | 0.092 0.029 DBMET02977 | DBMET02977 | |
| 0.137 | 0.167 | 0.162 | Histone acetyltransferase inhibitor | 0.162 0.123 DBMET02977 | DBMET02977 | |
| 0.032 | 0.062 | 0.074 | AICAR transformylase inhibitor | 0.074 0.009 DBMET02977 | DBMET02977 | |
| 0.04 | 0.07 | 0.071 | CD45 antagonist | 0.071 0.015 DBMET02977 | DBMET02977 | |
| 0.013 | 0.044 | 0.019 | Caspase 8 inhibitor | 0.019 0.015 DBMET02977 | DBMET02977 | |
| 0.082 | 0.114 | 0.157 | Protein kinase C gamma inhibitor | 0.157 0.027 DBMET02977 | DBMET02977 | |
| 0.005 | 0.036 | 0.011 | Thromboxane agonist | 0.011 0.007 DBMET02977 | DBMET02977 | |
| 0.025 | 0.056 | 0.058 | Retinoid X alpha receptor antagonist | 0.058 0.004 DBMET02977 | DBMET02977 | |
| 0.029 | 0.061 | 0.077 | Peroxisome proliferator-activated receptor alpha agonist | 0.077 0.019 DBMET02977 | DBMET02977 | |
| 0.034 | 0.067 | 0.063 | Glutamate (mGluR group III) antagonist | 0.063 0.012 DBMET02977 | DBMET02977 | |
| 0.009 | 0.043 | 0.031 | Angiotensin AT2 receptor antagonist | 0.031 0.013 DBMET02977 | DBMET02977 | |
| 0.112 | 0.146 | 0.151 | Adenylate cyclase stimulant | 0.151 0.061 DBMET02977 | DBMET02977 | |
| 0.037 | 0.073 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 DBMET02977 | DBMET02977 | |
| 0.087 | 0.123 | 0.113 | Bone formation stimulant | 0.113 0.092 DBMET02977 | DBMET02977 | |
| 0.05 | 0.087 | 0.06 | Bcl-xL inhibitor | 0.06 0.039 DBMET02977 | DBMET02977 | |
| 0.062 | 0.1 | 0.102 | GABA B receptor agonist | 0.102 0.015 DBMET02977 | DBMET02977 | |
| 0.012 | 0.05 | 0.049 | Retinoid X gamma receptor agonist | 0.049 0.005 DBMET02977 | DBMET02977 | |
| 0.019 | 0.057 | 0.033 | Retinoid X gamma receptor antagonist | 0.033 0.008 DBMET02977 | DBMET02977 | |
| 0.01 | 0.051 | 0.025 | Prostaglandin E2 agonist | 0.025 0.014 DBMET02977 | DBMET02977 | |
| 0.01 | 0.051 | 0.032 | Retinoic acid alpha receptor antagonist | 0.032 0.006 DBMET02977 | DBMET02977 | |
| 0.009 | 0.051 | 0.03 | Retinoic acid receptor antagonist | 0.03 0.005 DBMET02977 | DBMET02977 | |
| 0.08 | 0.122 | 0.103 | Amylase inhibitor | 0.103 0.094 DBMET02977 | DBMET02977 | |
| 0.014 | 0.058 | 0.033 | Retinoid X beta receptor antagonist | 0.033 0.004 DBMET02977 | DBMET02977 | |
| 0.013 | 0.057 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 DBMET02977 | DBMET02977 | |
| 0.065 | 0.111 | 0.236 | Alcohol dehydrogenase inhibitor | 0.236 0.009 DBMET02977 | DBMET02977 | |
| 0.042 | 0.089 | 0.079 | Leukotriene antagonist | 0.079 0.033 DBMET02977 | DBMET02977 | |
| 0.021 | 0.069 | 0.042 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.042 0.015 DBMET02977 | DBMET02977 | |
| 0.046 | 0.094 | 0.068 | Bcl2 antagonist | 0.068 0.045 DBMET02977 | DBMET02977 | |
| 0.02 | 0.068 | 0.046 | Diamine oxidase inhibitor | 0.046 0.018 DBMET02977 | DBMET02977 | |
| 0.042 | 0.091 | 0.059 | Leukotriene synthesis inhibitor | 0.059 0.057 DBMET02977 | DBMET02977 | |
| 0.098 | 0.147 | 0.212 | Protein-tyrosine phosphatase inhibitor | 0.212 0.042 DBMET02977 | DBMET02977 | |
| 0.038 | 0.087 | 0.059 | Androgen agonist | 0.059 0.043 DBMET02977 | DBMET02977 | |
| 0.01 | 0.059 | 0.038 | Retinoid X beta receptor agonist | 0.038 0.006 DBMET02977 | DBMET02977 | |
| 0.034 | 0.084 | 0.047 | Potassium channel (ATP-sensitive) activator | 0.047 0.037 DBMET02977 | DBMET02977 | |
| 0.006 | 0.057 | 0.015 | Retinoic acid receptor gamma antagonist | 0.015 0.005 DBMET02977 | DBMET02977 | |
| 0.035 | 0.086 | 0.049 | Potassium channel (Inward rectifier) activator | 0.049 0.038 DBMET02977 | DBMET02977 | |
| 0.01 | 0.061 | 0.076 | Methionyl aminopeptidase 2 inhibitor | 0.076 0.004 DBMET02977 | DBMET02977 | |
| 0.143 | 0.195 | 0.298 | 5 Hydroxytryptamine release stimulant | 0.298 0.07 DBMET02977 | DBMET02977 | |
| 0.043 | 0.095 | 0.077 | DNA gyrase inhibitor | 0.077 0.029 DBMET02977 | DBMET02977 | |
| 0.023 | 0.076 | 0.056 | Phosphorylase inhibitor | 0.056 0.027 DBMET02977 | DBMET02977 | |
| 0.062 | 0.115 | 0.147 | Urease inhibitor | 0.147 0.024 DBMET02977 | DBMET02977 | |
| 0.033 | 0.086 | 0.053 | Glucose-6-phosphate isomerase inhibitor | 0.053 0.025 DBMET02977 | DBMET02977 | |
| 0.115 | 0.169 | 0.249 | I kappa B kinase epsilon inhibitor | 0.249 0.038 DBMET02977 | DBMET02977 | |
| 0.034 | 0.09 | 0.054 | Leukotriene B4 antagonist | 0.054 0.037 DBMET02977 | DBMET02977 | |
| 0.038 | 0.093 | 0.159 | Phosphofructokinase-1 inhibitor | 0.159 0.016 DBMET02977 | DBMET02977 | |
| 0.014 | 0.07 | 0.12 | Kainate receptor 2 antagonist | 0.12 0.004 DBMET02977 | DBMET02977 | |
| 0.027 | 0.083 | 0.046 | Sphingosine kinase 1 inhibitor | 0.046 0.021 DBMET02977 | DBMET02977 | |
| 0.105 | 0.163 | 0.132 | LIM domain kinase 1 inhibitor | 0.132 0.119 DBMET02977 | DBMET02977 | |
| 0.045 | 0.103 | 0.204 | Glutamate decarboxylase inhibitor | 0.204 0.006 DBMET02977 | DBMET02977 | |
| 0.004 | 0.063 | 0.016 | Retinoic acid beta receptor antagonist | 0.016 0.005 DBMET02977 | DBMET02977 | |
| 0.03 | 0.09 | 0.06 | Carnitine palmitoyltransferase 1B inhibitor | 0.06 0.018 DBMET02977 | DBMET02977 | |
| 0.011 | 0.07 | 0.024 | Uridine phosphorylase inhibitor | 0.024 0.023 DBMET02977 | DBMET02977 | |
| 0.014 | 0.074 | 0.048 | Nicotinic acid receptor 2 antagonist | 0.048 0.004 DBMET02977 | DBMET02977 | |
| 0.049 | 0.109 | 0.204 | Glutamate dehydrogenase inhibitor | 0.204 0.01 DBMET02977 | DBMET02977 | |
| 0.025 | 0.086 | 0.056 | Sphingosine 1-phosphate receptor agonist | 0.056 0.02 DBMET02977 | DBMET02977 | |
| 0.026 | 0.088 | 0.063 | Xanthine dehydrogenase inhibitor | 0.063 0.036 DBMET02977 | DBMET02977 | |
| 0.066 | 0.128 | 0.091 | Lanosterol 14 alpha demethylase inhibitor | 0.091 0.071 DBMET02977 | DBMET02977 | |
| 0.017 | 0.079 | 0.154 | Kainate receptor antagonist | 0.154 0.005 DBMET02977 | DBMET02977 | |
| 0.045 | 0.107 | 0.076 | Cathepsin G inhibitor | 0.076 0.047 DBMET02977 | DBMET02977 | |
| 0.01 | 0.072 | 0.038 | 5-Alpha-reductase 2 inhibitor | 0.038 0.008 DBMET02977 | DBMET02977 | |
| 0.027 | 0.089 | 0.081 | Dihydroorotate dehydrogenase inhibitor | 0.081 0.017 DBMET02977 | DBMET02977 | |
| 0.052 | 0.115 | 0.106 | Glycine receptor agonist | 0.106 0.018 DBMET02977 | DBMET02977 | |
| 0.025 | 0.088 | 0.054 | Glutamate (mGluR8) agonist | 0.054 0.009 DBMET02977 | DBMET02977 | |
| 0.04 | 0.103 | 0.074 | Prostaglandin-E synthase inhibitor | 0.074 0.044 DBMET02977 | DBMET02977 | |
| 0.037 | 0.101 | 0.067 | Factor III inhibitor | 0.067 0.013 DBMET02977 | DBMET02977 | |
| 0.04 | 0.104 | 0.147 | Purinergic P2X1 antagonist | 0.147 0.007 DBMET02977 | DBMET02977 | |
| 0.06 | 0.125 | 0.141 | Prolactin inhibitor | 0.141 0.026 DBMET02977 | DBMET02977 | |
| 0.033 | 0.097 | 0.198 | Biliverdin reductase inhibitor | 0.198 0.006 DBMET02977 | DBMET02977 | |
| 0.012 | 0.077 | 0.032 | Prostaglandin EP4 antagonist | 0.032 0.014 DBMET02977 | DBMET02977 | |
| 0.016 | 0.082 | 0.046 | Farnesoid X receptor agonist | 0.046 0.017 DBMET02977 | DBMET02977 | |
| 0.021 | 0.088 | 0.046 | Glutamate (mGluR3) agonist | 0.046 0.006 DBMET02977 | DBMET02977 | |
| 0.006 | 0.074 | 0.029 | 5-Alpha-reductase 1 inhibitor | 0.029 0.009 DBMET02977 | DBMET02977 | |
| 0.063 | 0.131 | 0.201 | UDP-glucose 4-epimerase inhibitor | 0.201 0.018 DBMET02977 | DBMET02977 | |
| 0.061 | 0.129 | 0.235 | Creatine kinase inhibitor | 0.235 0.006 DBMET02977 | DBMET02977 | |
| 0.021 | 0.091 | 0.06 | Ribonucleoside-diphosphate reductase inhibitor | 0.06 0.034 DBMET02977 | DBMET02977 | |
| 0.06 | 0.131 | 0.16 | Falcipain 3 inhibitor | 0.16 0.032 DBMET02977 | DBMET02977 | |
| 0.101 | 0.171 | 0.13 | Heat shock protein 90 alpha antagonist | 0.13 0.111 DBMET02977 | DBMET02977 | |
| 0.02 | 0.092 | 0.062 | Ribonucleotide reductase inhibitor | 0.062 0.035 DBMET02977 | DBMET02977 | |
| 0.096 | 0.168 | 0.182 | Insulin secretagoues | 0.182 0.047 DBMET02977 | DBMET02977 | |
| 0.052 | 0.125 | 0.084 | Peroxisome proliferator-activated receptor gamma antagonist | 0.084 0.029 DBMET02977 | DBMET02977 | |
| 0.014 | 0.087 | 0.025 | Thyroid hormone agonist | 0.025 0.019 DBMET02977 | DBMET02977 | |
| 0.042 | 0.117 | 0.136 | Aminopeptidase I inhibitor | 0.136 0.015 DBMET02977 | DBMET02977 | |
| 0.062 | 0.139 | 0.12 | Topoisomerase II inhibitor | 0.12 0.067 DBMET02977 | DBMET02977 | |
| 0.044 | 0.121 | 0.065 | Ryanodine receptor antagonist | 0.065 0.026 DBMET02977 | DBMET02977 | |
| 0.015 | 0.093 | 0.048 | Carbonic anhydrase XII inhibitor | 0.048 0.039 DBMET02977 | DBMET02977 | |
| 0.033 | 0.111 | 0.074 | Carbonic anhydrase stimulant | 0.074 0.029 DBMET02977 | DBMET02977 | |
| 0.059 | 0.137 | 0.141 | Protein-tyrosine phosphatase 1B inhibitor | 0.141 0.049 DBMET02977 | DBMET02977 | |
| 0.049 | 0.129 | 0.184 | NMDA receptor antagonist | 0.184 0.017 DBMET02977 | DBMET02977 | |
| 0.067 | 0.147 | 0.114 | Histone deacetylase class III inhibitor | 0.114 0.076 DBMET02977 | DBMET02977 | |
| 0.014 | 0.094 | 0.049 | Fumarate hydratase inhibitor | 0.049 0.014 DBMET02977 | DBMET02977 | |
| 0.026 | 0.107 | 0.056 | Maillard reaction inhibitor | 0.056 0.037 DBMET02977 | DBMET02977 | |
| 0.032 | 0.115 | 0.061 | Peroxisome proliferator-activated receptor gamma agonist | 0.061 0.057 DBMET02977 | DBMET02977 | |
| 0.008 | 0.09 | 0.052 | Arginase inhibitor | 0.052 0.014 DBMET02977 | DBMET02977 | |
| 0.043 | 0.126 | 0.083 | Phospholipase D inhibitor | 0.083 0.029 DBMET02977 | DBMET02977 | |
| 0.01 | 0.094 | 0.039 | Leukotriene A4 hydrolase inhibitor | 0.039 0.025 DBMET02977 | DBMET02977 | |
| 0.038 | 0.123 | 0.074 | Protein kinase C beta inhibitor | 0.074 0.039 DBMET02977 | DBMET02977 | |
| 0.026 | 0.112 | 0.146 | NMDA 2C receptor antagonist | 0.146 0.007 DBMET02977 | DBMET02977 | |
| 0.175 | 0.262 | 0.394 | Antibacterial | 0.394 0.08 DBMET02977 | DBMET02977 | |
| 0.073 | 0.161 | 0.152 | M17 leucyl aminopeptidase inhibitor | 0.152 0.054 DBMET02977 | DBMET02977 | |
| 0.015 | 0.103 | 0.027 | Purinergic P2Y15 antagonist | 0.027 0.023 DBMET02977 | DBMET02977 | |
| 0.029 | 0.117 | 0.05 | Protein kinase C eta inhibitor | 0.05 0.043 DBMET02977 | DBMET02977 | |
| 0.052 | 0.142 | 0.067 | MDM2 inhibitor | 0.067 0.049 DBMET02977 | DBMET02977 | |
| 0.02 | 0.11 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.027 DBMET02977 | DBMET02977 | |
| 0.007 | 0.099 | 0.027 | NMDA receptor glycine site antagonist | 0.027 0.015 DBMET02977 | DBMET02977 | |
| 0.019 | 0.111 | 0.052 | GABA uptake inhibitor | 0.052 0.014 DBMET02977 | DBMET02977 | |
| 0.092 | 0.188 | 0.148 | Growth hormone agonist | 0.148 0.089 DBMET02977 | DBMET02977 | |
| 0.012 | 0.109 | 0.047 | NMDA 2D receptor antagonist | 0.047 0.008 DBMET02977 | DBMET02977 | |
| 0.01 | 0.108 | 0.029 | Lysine carboxypeptidase inhibitor | 0.029 0.016 DBMET02977 | DBMET02977 | |
| 0.034 | 0.133 | 0.091 | Dihydroorotate oxidase inhibitor | 0.091 0.006 DBMET02977 | DBMET02977 | |
| 0.023 | 0.123 | 0.079 | Plasminogen activator inhibitor antagonist | 0.079 0.015 DBMET02977 | DBMET02977 | |
| 0.011 | 0.112 | 0.048 | 5-Alpha-reductase inhibitor | 0.048 0.019 DBMET02977 | DBMET02977 | |
| 0.017 | 0.119 | 0.042 | Guanylate cyclase inhibitor | 0.042 0.03 DBMET02977 | DBMET02977 | |
| 0.017 | 0.119 | 0.046 | Sphingosine 1-phosphate receptor 1 agonist | 0.046 0.024 DBMET02977 | DBMET02977 | |
| 0.014 | 0.117 | 0.079 | NMDA receptor subunit 3A antagonist | 0.079 0.012 DBMET02977 | DBMET02977 | |
| 0.069 | 0.172 | 0.118 | DOPA decarboxylase inhibitor | 0.118 0.047 DBMET02977 | DBMET02977 | |
| 0.041 | 0.148 | 0.055 | Immunoglobulin Fc receptor antagonist | 0.055 0.037 DBMET02977 | DBMET02977 | |
| 0.016 | 0.124 | 0.031 | Dipeptidyl peptidase II inhibitor | 0.031 0.025 DBMET02977 | DBMET02977 | |
| 0.029 | 0.138 | 0.115 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.115 0.013 DBMET02977 | DBMET02977 | |
| 0.019 | 0.131 | 0.08 | Prostaglandin EP2 antagonist | 0.08 0.027 DBMET02977 | DBMET02977 | |
| 0.003 | 0.115 | 0.012 | Thrombopoietin agonist | 0.012 0.008 DBMET02977 | DBMET02977 | |
| 0.055 | 0.167 | 0.086 | MAP kinase kinase 7 inhibitor | 0.086 0.031 DBMET02977 | DBMET02977 | |
| 0.004 | 0.117 | 0.065 | Kainate receptor 1 antagonist | 0.065 0.005 DBMET02977 | DBMET02977 | |
| 0.032 | 0.145 | 0.348 | Porphobilinogen synthase inhibitor | 0.348 0.004 DBMET02977 | DBMET02977 | |
| 0.043 | 0.159 | 0.076 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.076 0.045 DBMET02977 | DBMET02977 | |
| 0.024 | 0.141 | 0.055 | Kainate receptor agonist | 0.055 0.01 DBMET02977 | DBMET02977 | |
| 0.004 | 0.123 | 0.031 | Prostaglandin H2 antagonist | 0.031 0.012 DBMET02977 | DBMET02977 | |
| 0.009 | 0.129 | 0.024 | Protease (Human cytomegalovirus) inhibitor | 0.024 0.012 DBMET02977 | DBMET02977 | |
| 0.059 | 0.179 | 0.13 | AMP-activated protein kinase stimulant | 0.13 0.041 DBMET02977 | DBMET02977 | |
| 0.013 | 0.136 | 0.03 | Glutamate (mGluR1) agonist | 0.03 0.01 DBMET02977 | DBMET02977 | |
| 0.016 | 0.142 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.023 DBMET02977 | DBMET02977 | |
| 0.021 | 0.148 | 0.045 | Glutamate (mGluR group III) agonist | 0.045 0.028 DBMET02977 | DBMET02977 | |
| 0.004 | 0.131 | 0.087 | AMPA 1 receptor antagonist | 0.087 0.006 DBMET02977 | DBMET02977 | |
| 0.055 | 0.188 | 0.109 | ABCA1 expression enhancer | 0.109 0.04 DBMET02977 | DBMET02977 | |
| 0.018 | 0.15 | 0.087 | NMDA receptor subunit 3B antagonist | 0.087 0.012 DBMET02977 | DBMET02977 | |
| 0.039 | 0.173 | 0.076 | Myeloperoxidase inhibitor | 0.076 0.075 DBMET02977 | DBMET02977 | |
| 0.027 | 0.164 | 0.114 | Phenylalanine 4-hydroxylase inhibitor | 0.114 0.02 DBMET02977 | DBMET02977 | |
| 0.061 | 0.199 | 0.153 | Thrombolytic | 0.153 0.079 DBMET02977 | DBMET02977 | |
| 0.07 | 0.208 | 0.131 | Interleukin 8 antagonist | 0.131 0.049 DBMET02977 | DBMET02977 | |
| 0.012 | 0.151 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.026 DBMET02977 | DBMET02977 | |
| 0.015 | 0.155 | 0.047 | Glutamate (mGluR3) antagonist | 0.047 0.014 DBMET02977 | DBMET02977 | |
| 0.069 | 0.214 | 0.175 | Mcl-1 antagonist | 0.175 0.07 DBMET02977 | DBMET02977 | |
| 0.049 | 0.195 | 0.213 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.213 0.014 DBMET02977 | DBMET02977 | |
| 0.131 | 0.28 | 0.252 | Transcription factor STAT inhibitor | 0.252 0.085 DBMET02977 | DBMET02977 | |
| 0.021 | 0.171 | 0.06 | Carbamoyl phosphate synthetase inhibitor | 0.06 0.043 DBMET02977 | DBMET02977 | |
| 0.069 | 0.219 | 0.119 | Anticoagulant | 0.119 0.113 DBMET02977 | DBMET02977 | |
| 0.017 | 0.168 | 0.164 | NMDA 2 receptor antagonist | 0.164 0.014 DBMET02977 | DBMET02977 | |
| 0.087 | 0.238 | 0.181 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.181 0.112 DBMET02977 | DBMET02977 | |
| 0.005 | 0.158 | 0.031 | Kainate receptor 5 antagonist | 0.031 0.009 DBMET02977 | DBMET02977 | |
| 0.027 | 0.189 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.04 DBMET02977 | DBMET02977 | |
| 0.035 | 0.203 | 0.149 | Protein kinase (CK2) alpha inhibitor | 0.149 0.042 DBMET02977 | DBMET02977 | |
| 0.005 | 0.173 | 0.03 | Somatostatin 5 antagonist | 0.03 0.023 DBMET02977 | DBMET02977 | |
| 0.044 | 0.213 | 0.126 | Cystathionine beta-synthase inhibitor | 0.126 0.054 DBMET02977 | DBMET02977 | |
| 0.014 | 0.187 | 0.034 | RNA-directed RNA polymerase inhibitor | 0.034 0.024 DBMET02977 | DBMET02977 | |
| 0.015 | 0.189 | 0.038 | Integrin alpha2 antagonist | 0.038 0.023 DBMET02977 | DBMET02977 | |
| 0.023 | 0.199 | 0.047 | Dopamine beta hydroxylase inhibitor | 0.047 0.037 DBMET02977 | DBMET02977 | |
| 0.028 | 0.205 | 0.085 | Prostaglandin F2 alpha antagonist | 0.085 0.019 DBMET02977 | DBMET02977 | |
| 0.011 | 0.192 | 0.025 | Integrin alpha2beta1 antagonist | 0.025 0.02 DBMET02977 | DBMET02977 | |
| 0.03 | 0.212 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.054 DBMET02977 | DBMET02977 | |
| 0.019 | 0.201 | 0.041 | Glutamate (mGluR8) antagonist | 0.041 0.016 DBMET02977 | DBMET02977 | |
| 0.004 | 0.187 | 0.028 | Nicotinic acid receptor 1 antagonist | 0.028 0.005 DBMET02977 | DBMET02977 | |
| 0.029 | 0.212 | 0.126 | Protein kinase (CK2) inhibitor | 0.126 0.045 DBMET02977 | DBMET02977 | |
| 0.02 | 0.203 | 0.056 | HIV-1 integrase (3'-Processing) inhibitor | 0.056 0.051 DBMET02977 | DBMET02977 | |
| 0.007 | 0.198 | 0.043 | TRPM8 blocker | 0.043 0.021 DBMET02977 | DBMET02977 | |
| 0.025 | 0.217 | 0.058 | Autotaxin inhibitor | 0.058 0.03 DBMET02977 | DBMET02977 | |
| 0.006 | 0.209 | 0.052 | AMPA 3 receptor antagonist | 0.052 0.008 DBMET02977 | DBMET02977 | |
| 0.042 | 0.245 | 0.074 | Vanilloid 4 agonist | 0.074 0.054 DBMET02977 | DBMET02977 | |
| 0.016 | 0.225 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.021 DBMET02977 | DBMET02977 | |
| 0.083 | 0.297 | 0.183 | Neurotrophic factor enhancer | 0.183 0.095 DBMET02977 | DBMET02977 | |
| 0.059 | 0.28 | 0.177 | Cell wall synthesis inhibitor | 0.177 0.042 DBMET02977 | DBMET02977 | |
| 0.014 | 0.241 | 0.076 | AMPA 4 receptor antagonist | 0.076 0.007 DBMET02977 | DBMET02977 | |
| 0.036 | 0.266 | 0.133 | HIV-1 integrase (Overall Integration) inhibitor | 0.133 0.033 DBMET02977 | DBMET02977 | |
| 0.022 | 0.255 | 0.048 | Topoisomerase II beta inhibitor | 0.048 0.037 DBMET02977 | DBMET02977 | |
| 0.027 | 0.26 | 0.064 | Glutamate (mGluR7) antagonist | 0.064 0.054 DBMET02977 | DBMET02977 | |
| 0.005 | 0.249 | 0.035 | Urate transporter 1 inhibitor | 0.035 0.033 DBMET02977 | DBMET02977 | |
| 0.075 | 0.32 | 0.157 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.157 0.06 DBMET02977 | DBMET02977 | |
| 0.005 | 0.281 | 0.049 | AMPA receptor antagonist | 0.049 0.032 DBMET02977 | DBMET02977 | |
| 0.008 | 0.285 | 0.052 | Prostaglandin E2 antagonist | 0.052 0.033 DBMET02977 | DBMET02977 | |
| 0.022 | 0.335 | 0.097 | Potassium channel (Ca-activated) activator | 0.097 0.058 DBMET02977 | DBMET02977 | |
| 0.045 | 0.367 | 0.09 | Hematopoietic | 0.09 0.049 DBMET02977 | DBMET02977 | |
| 0.072 | 0.416 | 0.127 | MAP kinase kinase 4 inhibitor | 0.127 0.124 DBMET02977 | DBMET02977 | |
| 0.025 | 0.4 | 0.101 | Uric acid excretion stimulant | 0.101 0.051 DBMET02977 | DBMET02977 | |
| 0.067 | 0.574 | 0.234 | Cyclophilin D inhibitor | 0.234 0.23 DBMET02977 | DBMET02977 | |
| 0.073 | 0.642 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.101 DBMET02977 | DBMET02977 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |